Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-27

Twist Bioscience Corp (TWST)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$13,781,570
Emily Leproust total, FY2025
88th
CEO pay percentile vs peers
73.2:1
CEO-to-median pay ratio
76.44%
Say-on-pay support, latest vote
Companies that benchmark against TWST
14 companies name TWST as a compensation peer

Each company listed discloses TWST in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TWST in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Emily Leproust$720,000$0$11,998,134$0$932,918$0$130,518$13,781,570
Chief Executive Officer and Chair of the Board
Patrick Finn563,00006,748,9470583,5920127,4038,022,942
President and Chief Operating Officer
Adam Laponis490,00003,365,4300349,197011,4904,216,117
Chief Financial Officer
Dennis Cho449,00002,872,0620290,88909,1253,621,076
Chief Legal Officer and Corporate Secretary
Paula Green400,00002,570,5370259,1440119,1783,348,859
Senior Vice President of Human Resources

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Emily Leproust$13,781,570$7,620,611$7,998,637+6,160,959
Patrick Finn8,022,9423,854,5515,227,858+4,168,391
Adam Laponis4,216,1175,008,244−792,127
Dennis Cho3,621,0761,798,4321,647,954+1,822,644
Paula Green3,348,8592,005,6812,487,420+1,343,178

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Adam LaponisChief Financial Officer2026-01-09D2,738$35$96,545CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-01-13D3,00040120,000CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13A3,279928,921CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13D3,27900Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13D23,27940931,160CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-23D2,39045107,330CommonForm 4 ↗
Emily M. LeproustDirector2026-02-03D5,00147232,927CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-03D1,0994751,187CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-03D7,00046319,536CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-03D2,70547125,988CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-03D175478,151CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-03D1,1944755,612CommonForm 4 ↗
Jan JohannessenDirector2026-02-05A5,09500CommonForm 4 ↗
Keith CrandellDirector2026-02-05A5,09500CommonForm 4 ↗
Jan JohannessenDirector2026-02-05D2,20048105,395CommonForm 4 ↗
Nelson C. ChanDirector2026-02-05A5,09500CommonForm 4 ↗
Trynka Shineman BlakeDirector2026-02-05A5,09500CommonForm 4 ↗
Robert ChessDirector2026-02-05A5,09500CommonForm 4 ↗
Robert RagusaDirector2026-02-05A5,09500CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-02-05A5,09500CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-09D2,00000CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-11D5,00050249,650CommonForm 4 ↗
Dividend-equivalent accruals2026-02-123,7121 insider, 4 accrual rows
Patrick FinnPresident and COO2026-02-12D3,50050175,788CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A7122718,982CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A1,5002739,990CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A1,0002323,330CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-02-12D7,00050350,000CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D1,7505087,572CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A5002311,665CommonForm 4 ↗
Robert ChessDirector2026-02-13D2,18448105,402CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D3,54153188,063CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D21,858501,099,916CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17A32,30027861,118CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D32,30000Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D16,61651854,445CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D26,952531,419,993CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D18,20500Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17A18,20523424,723CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-17D39,404522,064,770CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-23D8444739,423CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-23D1,4654768,430CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-23D1,6934779,080CommonForm 4 ↗
Emily M. LeproustDirector2026-02-23D7,20547336,544CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-23D4,29447200,572CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-02-23D2,0854797,390CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-03-06D2464611,421CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-03-06D9354643,408CommonForm 4 ↗
Dennis ChoSee Remarks2026-03-06D4254619,731CommonForm 4 ↗
Emily M. LeproustDirector2026-03-06D2,42346112,490CommonForm 4 ↗
Robert ChessDirector2026-03-17D10,00000Derivative, Class A CommonForm 4 ↗
Robert ChessDirector2026-03-17D10,00047470,000CommonForm 4 ↗
Robert ChessDirector2026-03-17A10,00012118,900CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-03-20D2974413,005CommonForm 4 ↗
Emily M. LeproustDirector2026-03-20D1,7424476,276CommonForm 4 ↗
Dennis ChoSee Remarks2026-03-20D3544415,500CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-04-01D1,0005151,000CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-09D2,59750129,562CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-14D3,00055165,000CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-17D4,00060240,000CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21D151669,966CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A1,610914,200CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A8,061971,098CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A8,06100Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-04-211,6101 insider, 1 accrual row
Emily M. LeproustDirector2026-04-21D1,61065104,666CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21D7,91065516,325CommonForm 4 ↗
Patrick FinnPresident and COO2026-04-23D2,32161141,026CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-04-27D5006230,915CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-05-04D1,1165763,778CommonForm 4 ↗
Emily M. LeproustDirector2026-05-04D5,12757293,002CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-04D1,96257112,126CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-04D164579,372CommonForm 4 ↗
Patrick FinnPresident and COO2026-05-04D2,84457162,531CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-08D4,96157282,187CommonForm 4 ↗
Jan JohannessenDirector2026-05-12A12,00000Derivative, Class A CommonForm 4 ↗
Jan JohannessenDirector2026-05-12D12,00056673,440CommonForm 4 ↗
Jan JohannessenDirector2026-05-12A12,00014168,000CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-21D1,6425387,448CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-05-21D1,3995374,507CommonForm 4 ↗
Patrick FinnPresident and COO2026-05-21D4,16053221,549CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-05-21D2,01953107,526CommonForm 4 ↗
Emily M. LeproustDirector2026-05-21D6,88853366,834CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-21D6885336,641CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A25,0179220,650CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D23,752651,549,561CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-26D8006249,987CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D1,2656683,846CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-05-26D5006130,520CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A24,2829214,167CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A24,28200Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D24,282651,580,246CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A25,01700Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D16,47000Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28A16,4709145,265CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-05-28D2,50068170,000CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D7,62368517,989CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D9006760,163CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D1,4826596,813CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D6,46569443,590CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-29D14,20570990,799CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-05-29D4,00070280,000CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D2327016,204CommonForm 4 ↗
Emily M. LeproustDirector2026-06-08D2,26570158,197CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-08D4027028,077CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D1,1276977,842CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D50000CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-08D8847061,742CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15A26,13723609,776CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D2,02882166,632CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D24,109821,967,856CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D26,13700Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-06-22D1,68887147,400CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-22D2918725,411CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-22D3468730,214CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-24D14,205901,274,899CommonForm 4 ↗
Emily M. LeproustDirector2026-06-25D18,880951,793,600CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-07-09D2,39994226,307CommonForm 4 ↗
Patrick FinnPresident and COO2026-07-23D2,23894210,133CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 122 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Adam LaponisChief Financial Officer2026-01-09D2,738$35$96,545CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-01-13D3,00040120,000CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13A3,279928,921CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13D3,27900Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-13D23,27940931,160CommonForm 4 ↗
Patrick FinnPresident and COO2026-01-23D2,39045107,330CommonForm 4 ↗
Emily M. LeproustDirector2026-02-03D5,00147232,927CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-03D1,0994751,187CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-03D7,00046319,536CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-03D2,70547125,988CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-03D175478,151CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-03D1,1944755,612CommonForm 4 ↗
Jan JohannessenDirector2026-02-05A5,09500CommonForm 4 ↗
Keith CrandellDirector2026-02-05A5,09500CommonForm 4 ↗
Jan JohannessenDirector2026-02-05D2,20048105,395CommonForm 4 ↗
Nelson C. ChanDirector2026-02-05A5,09500CommonForm 4 ↗
Trynka Shineman BlakeDirector2026-02-05A5,09500CommonForm 4 ↗
Robert ChessDirector2026-02-05A5,09500CommonForm 4 ↗
Robert RagusaDirector2026-02-05A5,09500CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-02-05A5,09500CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-09D2,00000CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-11D5,00050249,650CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D71200Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D3,50050175,788CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A7122718,982CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D50000Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A1,5002739,990CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A1,0002323,330CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-02-12D7,00050350,000CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D1,7505087,572CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12A5002311,665CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D1,50000Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-12D1,00000Derivative, Class A CommonForm 4 ↗
Robert ChessDirector2026-02-13D2,18448105,402CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D3,54153188,063CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D21,858501,099,916CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17A32,30027861,118CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D32,30000Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D16,61651854,445CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D26,952531,419,993CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17D18,20500Derivative, Class A CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-17A18,20523424,723CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-17D39,404522,064,770CommonForm 4 ↗
Dennis ChoSee Remarks2026-02-23D8444739,423CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-02-23D1,4654768,430CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-02-23D1,6934779,080CommonForm 4 ↗
Emily M. LeproustDirector2026-02-23D7,20547336,544CommonForm 4 ↗
Patrick FinnPresident and COO2026-02-23D4,29447200,572CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-02-23D2,0854797,390CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-03-06D2464611,421CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-03-06D9354643,408CommonForm 4 ↗
Dennis ChoSee Remarks2026-03-06D4254619,731CommonForm 4 ↗
Emily M. LeproustDirector2026-03-06D2,42346112,490CommonForm 4 ↗
Robert ChessDirector2026-03-17D10,00000Derivative, Class A CommonForm 4 ↗
Robert ChessDirector2026-03-17D10,00047470,000CommonForm 4 ↗
Robert ChessDirector2026-03-17A10,00012118,900CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-03-20D2974413,005CommonForm 4 ↗
Emily M. LeproustDirector2026-03-20D1,7424476,276CommonForm 4 ↗
Dennis ChoSee Remarks2026-03-20D3544415,500CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-04-01D1,0005151,000CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-09D2,59750129,562CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-14D3,00055165,000CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-04-17D4,00060240,000CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21D151669,966CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A1,610914,200CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A8,061971,098CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A8,06100Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21A1,61000Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21D1,61065104,666CommonForm 4 ↗
Emily M. LeproustDirector2026-04-21D7,91065516,325CommonForm 4 ↗
Patrick FinnPresident and COO2026-04-23D2,32161141,026CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-04-27D5006230,915CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-05-04D1,1165763,778CommonForm 4 ↗
Emily M. LeproustDirector2026-05-04D5,12757293,002CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-04D1,96257112,126CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-04D164579,372CommonForm 4 ↗
Patrick FinnPresident and COO2026-05-04D2,84457162,531CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-08D4,96157282,187CommonForm 4 ↗
Jan JohannessenDirector2026-05-12A12,00000Derivative, Class A CommonForm 4 ↗
Jan JohannessenDirector2026-05-12D12,00056673,440CommonForm 4 ↗
Jan JohannessenDirector2026-05-12A12,00014168,000CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-21D1,6425387,448CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-05-21D1,3995374,507CommonForm 4 ↗
Patrick FinnPresident and COO2026-05-21D4,16053221,549CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-05-21D2,01953107,526CommonForm 4 ↗
Emily M. LeproustDirector2026-05-21D6,88853366,834CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-21D6885336,641CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A25,0179220,650CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D23,752651,549,561CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-05-26D8006249,987CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D1,2656683,846CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-05-26D5006130,520CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A24,2829214,167CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A24,28200Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26D24,282651,580,246CommonForm 4 ↗
Emily M. LeproustDirector2026-05-26A25,01700Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D16,47000Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28A16,4709145,265CommonForm 4 ↗
Melissa A. StarovasnikDirector2026-05-28D2,50068170,000CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D7,62368517,989CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D9006760,163CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D1,4826596,813CommonForm 4 ↗
Emily M. LeproustDirector2026-05-28D6,46569443,590CommonForm 4 ↗
Dennis ChoSee Remarks2026-05-29D14,20570990,799CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-05-29D4,00070280,000CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D2327016,204CommonForm 4 ↗
Emily M. LeproustDirector2026-06-08D2,26570158,197CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-08D4027028,077CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D1,1276977,842CommonForm 4 ↗
Robert F. WernerChief Accounting Officer2026-06-08D50000CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-08D8847061,742CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15A26,13723609,776CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D2,02882166,632CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D24,109821,967,856CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-15D26,13700Derivative, Class A CommonForm 4 ↗
Emily M. LeproustDirector2026-06-22D1,68887147,400CommonForm 4 ↗
Paula GreenSVP of Human Resources2026-06-22D2918725,411CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-22D3468730,214CommonForm 4 ↗
Dennis ChoSee Remarks2026-06-24D14,205901,274,899CommonForm 4 ↗
Emily M. LeproustDirector2026-06-25D18,880951,793,600CommonForm 4 ↗
Adam LaponisChief Financial Officer2026-07-09D2,39994226,307CommonForm 4 ↗
Patrick FinnPresident and COO2026-07-23D2,23894210,133CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Adam LaponisPSU2024-12-0413,37326,74637,444$1,963,190
Adam LaponisRSU2024-12-0413,37326,746
Patrick FinnRSU2024-12-0426,81853,635
Emily LeproustRSU2024-12-0495,3504,999,201
Emily LeproustRSU2024-12-0447,67695,351
Paula GreenRSU2024-12-0420,4281,071,040
Patrick FinnRSU2024-12-0453,6342,812,031
Emily LeproustPSU2024-12-0447,67695,351133,4916,998,933
Paula GreenPSU2024-12-0410,21520,42928,6001,499,497
Dennis ChoRSU2024-12-0411,41322,825
Adam LaponisRSU2024-12-0426,7451,402,240
Dennis ChoPSU2024-12-0411,41322,82531,9551,675,400
Patrick FinnPSU2024-12-0426,81853,63575,0893,936,916
Paula GreenRSU2024-12-0410,21520,429
Dennis ChoRSU2024-12-0422,8241,196,662
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Adam Laponis$1,428,986$1,963,190$057.9%
Patrick Finn2,865,6663,936,916057.9%
Emily Leproust5,094,5526,998,933057.9%
Paula Green1,091,4691,499,497057.9%
Dennis Cho1,219,4871,675,400057.9%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Emily LeproustPSU77,473$2,180,090
Emily LeproustPSU40,4311,137,728
Adam LaponisPSU37,4441,053,674
Adam LaponisPSU21,732611,538
Patrick FinnPSU9,572269,356
Paula GreenPSU16,600467,124
Patrick FinnPSU37910,665
Paula GreenOption026.66
Paula GreenOption023.33
Emily LeproustOption026.66
Paula GreenOption067.85
Emily LeproustOption023.33
Emily LeproustOption08.82
Emily LeproustPSU48,5131,365,156
Emily LeproustPSU133,4913,756,437
Patrick FinnPSU44,8831,263,008
Paula GreenPSU35,513999,336
Patrick FinnPSU11,090312,073
Dennis ChoPSU4,710132,539
Dennis ChoPSU3429,624
Dennis ChoPSU31,955899,214
Emily LeproustPSU27,573775,904
Paula GreenPSU19,980562,237
Dennis ChoPSU6,000168,840
Dennis ChoOption8,194115.93
Paula GreenPSU2908,161
Patrick FinnOption026.66
Paula GreenOption08.82
Emily LeproustPSU168,9764,754,985
Paula GreenPSU3,04585,686
Dennis ChoPSU16,605467,265
Dennis ChoPSU3,19289,823
Patrick FinnOption08.82
Emily LeproustOption067.85
Patrick FinnOption067.85
Patrick FinnPSU18,000506,520
Patrick FinnOption023.33
Paula GreenPSU15,000422,100
Paula GreenPSU18,000506,520
Adam LaponisPSU46,8781,319,147
Adam LaponisPSU37,0001,041,180
Dennis ChoPSU29,518830,637
Paula GreenPSU28,600804,804
Emily LeproustPSU18,675525,515
Dennis ChoPSU18,546521,884
Patrick FinnPSU16,373460,736
Patrick FinnPSU14,131397,646
Dennis ChoPSU7,200202,608
Paula GreenPSU4,491126,377
Emily LeproustPSU1,05329,631
Emily LeproustPSU95,0492,674,679
05

Incentive-plan design — the Compensation Discussion & Analysis

Provide a significant portion of compensation through variable, performance-based components that are at-risk and based on satisfaction of designated financial and non-financial objectives

CEO STI target (% of salary)100%
CEO LTI target (% of salary)
Independent consultant
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-02-0638,430,67311,842,36732,66376.44%Passed
20252025-02-0549,586,4861,201,24130,57197.63%Passed
20242024-02-0643,215,5712,904,71431,87493.7%Passed
20232023-02-0743,379,2953,746,99630,00392.05%Passed
20222022-02-0836,736,9355,872,41429,14586.22%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-02-0676.44%a
20252025-02-0597.63%b
20242024-02-0693.7%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect and will not be counted towards the vote totals for proposals 2 and 3.”.

b. Approved under the standard stated in the filing — “If you abstain from voting on Proposal 2, the abstention will have no effect on the outcome of the non-binding, advisory vote to approve the compensation of the Company's named executive officers, as disclosed in this proxy statement.”.

c. Approved under the standard stated in the filing — “If you ABSTAIN from voting on proposal 2, the abstention will have no effect on the outcome of the non-binding, advisory vote to approve the compensation of the Company's named executive officers, as disclosed in this proxy statement.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)73.2 : 1
CEO total compensation$13,781,570
Median employee compensation$188,208
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Trynka Shineman BlakeIndependent · Audit and Risk · Newly elected$9,000$394,995$0$0$403,995
Robert ChessIndependent · Lead Independent Director · Compensation · Nominating and Corporate Governance (Chair)97,500239,96800337,468
Jan JohannessenIndependent · Audit and Risk (Chair) · Nominating and Corporate Governance73,750239,96800313,718
Nelson C. ChanIndependent · Audit and Risk · Nominating and Corporate Governance72,500239,96800312,468
Melissa A. StarovasnikIndependent · Compensation (Chair)65,000239,96800304,968
Robert RagusaIndependent · Audit and Risk · Compensation65,000239,96800304,968
Keith CrandellIndependent · Compensation · Nominating and Corporate Governance60,000239,96800299,968
Xiaoying MaiIndependent · Departed during FY33,39300148,559181,952
Emily M. LeproustEmployee director · Board Chair · Compensation (Chair)00000
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$239,968
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)22,500 / 17,500 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$476,143
Equity awards (grant-date value)$1,834,803
All other compensation$148,559
Total cost of the board$2,459,505

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Twist Bioscience Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Twist Bioscience Corp.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Natera, Inc.2025Steven Chapman$853,710$12,979,558$0$1,114,151$14,957,319
2Insmed Incorporated2025William Lewis854,5502,999,9409,000,0331,495,46314,467,393
3Twist Bioscience Corp2025Emily Leproust720,00011,998,1340932,91813,781,570
4NovoCure Limited2025Ashley Cordova901,8378,249,9652,752,814811,65313,198,354
5Ultragenyx Pharmaceutical Inc.2025Emil Kakkis861,1008,364,9381,847,356299,66311,405,535
6Azenta, Inc.2025John Marotta900,0008,386,29701,063,65610,371,414
7Maravai LifeSciences Holdings, Inc.2025Bernd Brust388,8637,660,0001,460,000425,34310,129,708
8NeoGenomics, Inc.2025Tony Zook601,5393,999,9973,998,235513,4009,127,092
9Guardant Health, Inc.2025AmirAli Talasaz18,647,709008,661,227
10Veracyte, Inc.2025Marc Stapley700,0005,890,8770826,0007,421,877
11CareDx, Inc.2025John Hanna693,2695,622,6380852,5157,179,699
12BioLife Solutions, Inc.2024Roderick de Greef744,4505,571,8740655,1167,046,205
1310x Genomics, Inc.2025Serge Saxonov674,2505,020,2690634,7256,329,244
14Quanterix Corporation2025Masoud Toloue670,9501,170,0002,729,998674,1725,250,745
15Cytek Biosciences, Inc.2025Wenbin Jiang620,0002,000,0002,000,000485,2115,120,061
16Pacific Biosciences of California, Inc.2025Christian Henry748,2501,151,0131,696,278714,3054,309,846
17REGENXBIO Inc.2025Curran Simpson665,510777,4482,350,302387,3274,200,712
18Schrödinger, Inc.2025Ramy Farid730,000796,5001,966,876570,8604,079,043

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Twist Bioscience Corp129.6%PSU 50 · RSU 50Nonot disclosed
10x Genomics, Inc.93%PSU 60 · RSU 40Yes — 3-year Relative TSRAlpine Rewards LLC
Azenta, Inc.107.4%PSU 50 · RSU 50Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer
BioLife Solutions, Inc.88%RSU 50 · PSU 50Yes — Total Shareholder Return (TSR)Frederic W. Cook & Co, Inc.
CareDx, Inc.122%RSU 70 · PSU 30NoAlpine Rewards
Cytek Biosciences, Inc.78.4%RSU 50 · Options 50not disclosedMeridian Compensation Partners, LLC
Guardant Health, Inc.140%PSU 50 · RSU 50NoAon
Insmed Incorporated175%Options 75 · RSU 25NoWillis Towers Watson (WTW)
Maravai LifeSciences Holdings, Inc.not disclosednot disclosedNoMeridian Compensation Partners, LLC
Natera, Inc.131.1%PSU 50 · RSU 50NoAon
NeoGenomics, Inc.60%RSU 50 · Options 50not disclosedWTW
NovoCure Limited100%PSU 50 · RSU 25 · Options 25NoFrederic W. Cook & Co., Inc.
Pacific Biosciences of California, Inc.95%not disclosednot disclosedAon Human Capital Solutions
Quanterix Corporation95%Options 70 · RSU 30not disclosedPayGov
REGENXBIO Inc.97%Options 75 · RSU 25not disclosedWillis Towers Watson
Schrödinger, Inc.92%not disclosedNoAon
Ultragenyx Pharmaceutical Inc.44%PSU 60 · RSU 20 · Options 20Yes — Relative TSRAon's Human Capital Solutions Practice
Veracyte, Inc.118%PSU 50 · RSU 50NoAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

FAQ

Frequently asked questions

Who was the highest-paid executive at Twist Bioscience Corp in fiscal 2025?
As disclosed, the highest-paid executive was Emily Leproust, who served as Chief Executive Officer and Chair of the Board with total compensation of $13,781,570.
How does Twist Bioscience Corp's chief executive pay compare to its disclosed peer group?
The filing shows the CEO's pay was at the 88th percentile of the disclosed peer group.
What is Twist Bioscience Corp's CEO-to-median employee pay ratio?
The company reported a CEO-to-median employee pay ratio of 73.2:1.
How did shareholders vote on Twist Bioscience Corp's executive compensation?
Shareholders provided 76.44% support in the latest vote on executive compensation.
How much does Twist Bioscience Corp spend in total on board compensation for fiscal 2025?
The total board compensation for fiscal 2025 was $2,459,505.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Emily LeproustDEF 14A2026-01-060001581280-26-000006Section “Summary Compensation Table” · page 43. As printed: 13,781,570. Filing ↗machine: t34 · r2 · c15 · span 1510951–1510961
2Section 01, Patrick FinnDEF 14A2026-01-060001581280-26-000006Section “Summary Compensation Table” · page 43. As printed: 8,022,942. Filing ↗machine: t34 · r7 · c15 · span 1541554–1541563
3Section 01, Adam LaponisDEF 14A2026-01-060001581280-26-000006Section “Summary Compensation Table” · page 43. As printed: 4,216,117. Filing ↗machine: t34 · r5 · c15 · span 1528424–1528433
4Section 01, Dennis ChoDEF 14A2026-01-060001581280-26-000006Section “Summary Compensation Table” · page 43. As printed: 3,621,076. Filing ↗machine: t34 · r13 · c15 · span 1577450–1577459
5Section 01, Paula GreenDEF 14A2026-01-060001581280-26-000006Section “Summary Compensation Table” · page 43. As printed: 3,348,859. Filing ↗machine: t34 · r10 · c15 · span 1559702–1559711
6Section 03, Adam Laponis PSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r3 · c4 · span 1274514–1274520
7Section 03, Adam Laponis RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r8 · c12 · span 1657185–1657191
8Section 03, Patrick Finn RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r11 · c12 · span 1670606–1670612
9Section 03, Emily Leproust RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r2 · c6 · span 1272578–1272584
10Section 03, Emily Leproust RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r5 · c12 · span 1644952–1644958
11Section 03, Paula Green RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r5 · c6 · span 1280221–1280227
12Section 03, Patrick Finn RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r4 · c6 · span 1277675–1277681
13Section 03, Emily Leproust PSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r2 · c4 · span 1271914–1271920
14Section 03, Paula Green PSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r5 · c4 · span 1279616–1279622
15Section 03, Dennis Cho RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r17 · c12 · span 1696272–1696278
16Section 03, Adam Laponis RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r3 · c6 · span 1275117–1275123
17Section 03, Dennis Cho PSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r6 · c4 · span 1282164–1282170
18Section 03, Patrick Finn PSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r4 · c4 · span 1277069–1277075
19Section 03, Paula Green RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r14 · c12 · span 1682850–1682856
20Section 03, Dennis Cho RSUDEF 14A2026-01-060001581280-26-000006Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r6 · c6 · span 1282770–1282776
21Section 07, pay ratioDEF 14A2026-01-060001581280-26-000006Section “CEO Pay Ratio”. As printed: 73.2 : 1. Filing ↗machine: t42 · r1 · c1 · span 2421139–2421146
22Section 08, Trynka Shineman BlakeDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 403,995. Filing ↗machine: t11 · r8 · c12 · span 427365–427372
23Section 08, Robert ChessDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 337,468. Filing ↗machine: t11 · r3 · c12 · span 402132–402139
24Section 08, Jan JohannessenDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 313,718. Filing ↗machine: t11 · r5 · c12 · span 412302–412309
25Section 08, Nelson C. ChanDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 312,468. Filing ↗machine: t11 · r2 · c12 · span 397046–397053
26Section 08, Melissa A. StarovasnikDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 304,968. Filing ↗machine: t11 · r9 · c12 · span 432475–432482
27Section 08, Robert RagusaDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 304,968. Filing ↗machine: t11 · r7 · c12 · span 422258–422265
28Section 08, Keith CrandellDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 299,968. Filing ↗machine: t11 · r4 · c12 · span 407213–407220
29Section 08, Xiaoying MaiDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 181,952. Filing ↗machine: t11 · r6 · c12 · span 417164–417171
30Section 08, Emily M. LeproustDEF 14A2026-01-060001581280-26-000006Section “Director Compensation”. As printed: 0. Filing ↗
31Section 02, Adam Laponis 2026-01-09Form 42026-01-130001214659-26-000423Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Adam Laponis 2026-01-13Form 42026-01-150001214659-26-000509Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Patrick Finn 2026-01-13Form 42026-01-150001214659-26-000508Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Patrick Finn 2026-01-13Form 42026-01-150001214659-26-000508Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Patrick Finn 2026-01-13Form 42026-01-150001214659-26-000508Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Patrick Finn 2026-01-23Form 42026-01-270001214659-26-000873Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Emily M. Leproust 2026-02-03Form 42026-02-050001214659-26-001240Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Dennis Cho 2026-02-03Form 42026-02-050001214659-26-001236Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Robert F. Werner 2026-02-03Form 42026-02-050001214659-26-001239Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Patrick Finn 2026-02-03Form 42026-02-050001214659-26-001237Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Robert F. Werner 2026-02-03Form 42026-02-050001214659-26-001239Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Paula Green 2026-02-03Form 42026-02-050001214659-26-001238Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Jan Johannessen 2026-02-05Form 42026-02-090001214659-26-001339Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Keith Crandell 2026-02-05Form 42026-02-090001214659-26-001352Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Jan Johannessen 2026-02-05Form 42026-02-090001214659-26-001339Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Nelson C. Chan 2026-02-05Form 42026-02-090001214659-26-001341Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Trynka Shineman Blake 2026-02-05Form 42026-02-090001214659-26-001340Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Robert Chess 2026-02-05Form 42026-02-090001214659-26-001342Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Robert Ragusa 2026-02-05Form 42026-02-090001214659-26-001343Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Melissa A. Starovasnik 2026-02-05Form 42026-02-090001214659-26-001344Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Robert F. Werner 2026-02-09Form 42026-02-110001214659-26-001492Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Dennis Cho 2026-02-11Form 42026-02-130001214659-26-001724Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Adam Laponis 2026-02-12Form 42026-02-130001214659-26-001737Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Patrick Finn 2026-02-12Form 42026-02-170001214659-26-002041Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Robert Chess 2026-02-13Form 42026-02-180001214659-26-002125Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Patrick Finn 2026-02-17Form 42026-02-190001214659-26-002179Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Paula Green 2026-02-17Form 42026-02-190001214659-26-002180Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Dennis Cho 2026-02-23Form 42026-02-250001214659-26-002446Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Paula Green 2026-02-23Form 42026-02-250001214659-26-002447Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Robert F. Werner 2026-02-23Form 42026-02-250001214659-26-002443Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Emily M. Leproust 2026-02-23Form 42026-02-250001214659-26-002441Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Patrick Finn 2026-02-23Form 42026-02-250001214659-26-002445Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Adam Laponis 2026-02-23Form 42026-02-250001214659-26-002442Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Robert F. Werner 2026-03-06Form 42026-03-100001214659-26-003067Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Paula Green 2026-03-06Form 42026-03-100001214659-26-003064Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Dennis Cho 2026-03-06Form 42026-03-100001214659-26-003065Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Emily M. Leproust 2026-03-06Form 42026-03-100001214659-26-003063Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Robert Chess 2026-03-17Form 42026-03-190001214659-26-003483Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Robert Chess 2026-03-17Form 42026-03-190001214659-26-003483Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Robert Chess 2026-03-17Form 42026-03-190001214659-26-003483Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Paula Green 2026-03-20Form 42026-03-240001214659-26-003722Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Emily M. Leproust 2026-03-20Form 42026-03-240001214659-26-003721Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Dennis Cho 2026-03-20Form 42026-03-240001214659-26-003723Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Melissa A. Starovasnik 2026-04-01Form 42026-04-030001214659-26-004333Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Adam Laponis 2026-04-09Form 42026-04-130001214659-26-004601Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Adam Laponis 2026-04-14Form 42026-04-160001214659-26-004735Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Adam Laponis 2026-04-17Form 42026-04-210001214659-26-004893Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Emily M. Leproust 2026-04-21Form 42026-04-230001214659-26-005005Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Patrick Finn 2026-04-23Form 42026-04-270001214659-26-005124Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Melissa A. Starovasnik 2026-04-27Form 42026-04-290001214659-26-005250Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Paula Green 2026-05-04Form 42026-05-060001214659-26-005673Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Emily M. Leproust 2026-05-04Form 42026-05-060001214659-26-005675Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Dennis Cho 2026-05-04Form 42026-05-060001214659-26-005676Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Robert F. Werner 2026-05-04Form 42026-05-060001214659-26-005672Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Patrick Finn 2026-05-04Form 42026-05-060001214659-26-005674Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Robert F. Werner 2026-05-08Form 42026-05-120001214659-26-005987Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Jan Johannessen 2026-05-12Form 42026-05-140001214659-26-006205Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Jan Johannessen 2026-05-12Form 42026-05-140001214659-26-006205Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Jan Johannessen 2026-05-12Form 42026-05-140001214659-26-006205Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Dennis Cho 2026-05-21Form 42026-05-260001214659-26-006709Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Paula Green 2026-05-21Form 42026-05-260001214659-26-006711Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Patrick Finn 2026-05-21Form 42026-05-260001214659-26-006710Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Adam Laponis 2026-05-21Form 42026-05-260001214659-26-006712Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Emily M. Leproust 2026-05-21Form 42026-05-260001214659-26-006713Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Robert F. Werner 2026-05-21Form 42026-05-260001214659-26-006714Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Robert F. Werner 2026-05-26Form 42026-05-280001214659-26-006834Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Melissa A. Starovasnik 2026-05-26Form 42026-05-280001214659-26-006833Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Emily M. Leproust 2026-05-26Form 42026-05-280001214659-26-006835Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Melissa A. Starovasnik 2026-05-28Form 42026-06-010001214659-26-006966Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Emily M. Leproust 2026-05-28Form 42026-06-010001214659-26-006967Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Dennis Cho 2026-05-29Form 42026-06-020001214659-26-007030Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Adam Laponis 2026-05-29Form 42026-06-020001214659-26-007029Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Robert F. Werner 2026-06-08Form 42026-06-100001214659-26-007315Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Emily M. Leproust 2026-06-08Form 42026-06-100001214659-26-007316Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Dennis Cho 2026-06-08Form 42026-06-100001214659-26-007318Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Robert F. Werner 2026-06-08Form 42026-06-100001214659-26-007315Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Robert F. Werner 2026-06-08Form 42026-06-100001214659-26-007315Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Paula Green 2026-06-08Form 42026-06-100001214659-26-007317Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Paula Green 2026-06-15Form 42026-06-170001214659-26-007525Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Paula Green 2026-06-15Form 42026-06-170001214659-26-007525Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Paula Green 2026-06-15Form 42026-06-170001214659-26-007525Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Paula Green 2026-06-15Form 42026-06-170001214659-26-007525Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Emily M. Leproust 2026-06-22Form 42026-06-240001214659-26-007692Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Paula Green 2026-06-22Form 42026-06-240001214659-26-007694Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Dennis Cho 2026-06-22Form 42026-06-240001214659-26-007693Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Dennis Cho 2026-06-24Form 42026-06-260001214659-26-007793Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Emily M. Leproust 2026-06-25Form 42026-06-260001214659-26-007800Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Adam Laponis 2026-07-09Form 42026-07-130001214659-26-008480Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, Patrick Finn 2026-07-23Form 42026-07-270001214659-26-009065Insider equity transaction reported since the proxy statement. Filing ↗
153Section 06, 2026 voteForm 8-K2026-02-060001581280-26-000022Item 5.07 · say-on-pay result. As reported: 76.44% (votes for as printed: 38,430,673). Filing ↗
154Section 06, 2025 voteForm 8-K2025-02-110001104659-25-011543Item 5.07 · say-on-pay result. As reported: 97.63% (votes for as printed: 49,586,486). Filing ↗
155Section 06, 2024 voteForm 8-K2024-02-070001104659-24-011607Item 5.07 · say-on-pay result. As reported: 93.7% (votes for as printed: 43,215,571). Filing ↗
156Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
157Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
158Section 09b board cost (computed)ComputedcomputedCash 476,143 + equity 1,834,803 + all other 148,559 = 2,459,505, summed across the director compensation table rows.machine: formula: Σ = 2,459,505
159Natera, Inc., Section 10b CEO totalDEF 14A2026-04-230001104659-26-047770CEO total compensation as printed in Natera, Inc.'s own proxy. As printed: 14,957,319. Filing ↗machine: t190 · r5 · c14 · span 1269868–1269878
160Insmed Incorporated, Section 10b CEO totalDEF 14A2026-04-010001104506-26-000022CEO total compensation as printed in Insmed Incorporated's own proxy. As printed: 14,467,393. Filing ↗machine: r4 · c51 · span 912553–912563
161Twist Bioscience Corp (subject), Section 10b CEO totalDEF 14A2026-01-060001581280-26-000006CEO total compensation as printed in Twist Bioscience Corp's own proxy. As printed: 13,781,570. Filing ↗machine: t34 · r2 · c15 · span 1510951–1510961
162NovoCure Limited, Section 10b CEO totalDEF 14A2026-04-200001645113-26-000033CEO total compensation as printed in NovoCure Limited's own proxy. As printed: 13,198,354. Filing ↗machine: r6 · c48 · span 880842–880852
163Ultragenyx Pharmaceutical Inc., Section 10b CEO totalDEF 14A2026-03-270001308179-26-000174CEO total compensation as printed in Ultragenyx Pharmaceutical Inc.'s own proxy. As printed: 11,405,535. Filing ↗machine: span 668997–669007
164Azenta, Inc., Section 10b CEO totalDEF 14A2025-12-180001140361-25-046064CEO total compensation as printed in Azenta, Inc.'s own proxy. As printed: 10,371,414. Filing ↗machine: r2 · c22 · span 1247118–1247129
165Maravai LifeSciences Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-240001823239-26-000014CEO total compensation as printed in Maravai LifeSciences Holdings, Inc.'s own proxy. As printed: 10,129,708. Filing ↗machine: t21 · r3 · c20 · span 502645–502655
166NeoGenomics, Inc., Section 10b CEO totalDEF 14A2026-04-060001077183-26-000014CEO total compensation as printed in NeoGenomics, Inc.'s own proxy. As printed: 9,127,092. Filing ↗machine: r2 · c45 · span 869460–869469
167Guardant Health, Inc., Section 10b CEO totalDEF 14A2026-04-280001193125-26-187403CEO total compensation as printed in Guardant Health, Inc.'s own proxy. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158
168Veracyte, Inc., Section 10b CEO totalDEF 14A2026-04-220001384101-26-000021CEO total compensation as printed in Veracyte, Inc.'s own proxy. As printed: 7,421,877. Filing ↗machine: r4 · c27 · span 855413–855422
169CareDx, Inc., Section 10b CEO totalDEF 14A2026-04-270001217234-26-000028CEO total compensation as printed in CareDx, Inc.'s own proxy. As printed: 7,179,699. Filing ↗machine: t113 · r3 · c9 · span 1893652–1893661
170BioLife Solutions, Inc., Section 10b CEO totalDEF 14A2025-07-080000834365-25-000007CEO total compensation as printed in BioLife Solutions, Inc.'s own proxy. As printed: 7,046,205. Filing ↗machine: t19 · r3 · c19 · span 344908–344917
17110x Genomics, Inc., Section 10b CEO totalDEF 14A2026-04-240001628280-26-027201CEO total compensation as printed in 10x Genomics, Inc.'s own proxy. As printed: 6,329,244. Filing ↗machine: r3 · c48 · span 583283–583292
172Quanterix Corporation, Section 10b CEO totalDEF 14A2026-04-240001104659-26-048166CEO total compensation as printed in Quanterix Corporation's own proxy. As printed: 5,250,745. Filing ↗machine: t18 · r1 · c47 · span 503076–503085
173Cytek Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-280001140361-26-017479CEO total compensation as printed in Cytek Biosciences, Inc.'s own proxy. As printed: 5,120,061. Filing ↗machine: r2 · c21 · span 561243–561252
174Pacific Biosciences of California, Inc., Section 10b CEO totalDEF 14A2026-04-230001299130-26-000064CEO total compensation as printed in Pacific Biosciences of California, Inc.'s own proxy. As printed: 4,309,846. Filing ↗machine: r2 · c48 · span 876974–876983
175REGENXBIO Inc., Section 10b CEO totalDEF 14A2026-04-140001193125-26-155058CEO total compensation as printed in REGENXBIO Inc.'s own proxy. As printed: 4,200,712. Filing ↗machine: r2 · c16 · span 436444–436453
176Schrödinger, Inc., Section 10b CEO totalDEF 14A2026-04-280001490978-26-000026CEO total compensation as printed in Schrödinger, Inc.'s own proxy. As printed: 4,079,043. Filing ↗machine: span 722763–722772
177Section 10a, Quanterix Corporation reciprocityDEF 14A0001104659-26-048166Quanterix Corporation names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
178Section 10a, BioLife Solutions, Inc. reciprocityDEF 14A0000834365-25-000007BioLife Solutions, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
179Section 10a, Veracyte, Inc. reciprocityDEF 14A0001384101-26-000021Veracyte, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
180Section 10a, Schrödinger, Inc. reciprocityDEF 14A0001490978-26-000026Schrödinger, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
181Section 10a, Ultragenyx Pharmaceutical Inc. reciprocityDEF 14A0001308179-26-000174Ultragenyx Pharmaceutical Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
182Section 10a, Pacific Biosciences of California, Inc. reciprocityDEF 14A0001299130-26-000064Pacific Biosciences of California, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
183Section 10a, Cytek Biosciences, Inc. reciprocityDEF 14A0001140361-26-017479Cytek Biosciences, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
184Section 10a, NovoCure Limited reciprocityDEF 14A0001645113-26-000033NovoCure Limited's most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
185Section 10a, 10x Genomics, Inc. reciprocityDEF 14A0001628280-26-02720110x Genomics, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
186Section 10a, Insmed Incorporated reciprocityDEF 14A0001104506-26-000022Insmed Incorporated's most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
187Section 10a, Azenta, Inc. reciprocityDEF 14A0001140361-25-046064Azenta, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
188Section 10a, Maravai LifeSciences Holdings, Inc. reciprocityDEF 14A0001823239-26-000014Maravai LifeSciences Holdings, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
189Section 10a, Natera, Inc. reciprocityDEF 14A0001104659-26-047770Natera, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
190Section 10a, CareDx, Inc. reciprocityDEF 14A0001217234-26-000028CareDx, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
191Section 10a, NeoGenomics, Inc. reciprocityDEF 14A0001077183-26-000014NeoGenomics, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗
192Section 10a, Guardant Health, Inc. reciprocityDEF 14A0001193125-26-187403Guardant Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗